 
                  
Pfizer allows other companies to manufacture its COVID-19 pill
Earlier this month, Pfizer said its pill curtailed the hazard of hospitalisation and mortality by almost 90% in people with mild to moderate COVID-19 viruses. Independent specialists suggested pausing the company’s study based on its likely results.
 
